
Opinion|Videos|June 12, 2024
Final Insights on Current Bladder Cancer Clinical Trials
Author(s)Neal Shore, MD
Neal Shore, MD, FACS, shares his final thoughts on the current landscape of clinical trials for both non-muscle-invasive bladder cancer and muscle-invasive bladder cancer, providing insights into the potential impact and future directions of these studies.
Advertisement
Episodes in this series

Video content above is prompted by the following question(s):
- Based on the data presented, how might these novel therapeutic approaches potentially change the standard of care and clinical management of NMIBC and MIBC in the future?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NIH Grant Terminations Disrupt 1 in 30 Clinical Trials, Impacting Over 74,000 Participants
2
Rescue Therapy With Rozanolixizumab Promising in Triple-Seronegative MG
3
How Effective and Safe Are GLP-1s for Weight Loss?
4
FDA Approves Plozasiran to Reduce Triglycerides in Familial Chylomicronemia Syndrome
5












































